Cover image of the article: Hypertension and aeromedical considerations

Image Credit:Ann Mil Health Sci Res

Hypertension and aeromedical considerations

Authors

Mahmud momenzadeh1,*, Ahmad ebadi2, Reza eslami2, Amir khoshvaghti3
1Researcher, Aerospace and subaquatic medicine school, AJA University of medical sciences, Tehran, Iran, Andorra
2Researcher, Aerospace medicine research center, Aerospace and subaquatic medicine school, AJA University of medical sciences, Tehran, Iran, Andorra
3Assistant Professor, Aerospace medicine research center, Aerospace and subaquatic medicine school, AJA University of medical sciences, Tehran, Iran, Andorra
*Corresponding Author: Corresponding author: Mahmud momenzadeh, Researcher, Aerospace and subaquatic medicine school, AJA University of medical sciences, Tehran, Iran, Andorra Email: mgmahmood@yahoo.com

Annals of Military and Health Sciences Research:Vol. 11, issue 4; e65022
Published online:Oct 28, 2013
Article type:Research Article
Received:Jul 21, 2013
Accepted:Sep 28, 2013
How to Cite:momenzadeh M, ebadi A, eslami R, khoshvaghti A. Hypertension and aeromedical considerations. Ann Mil Health Sci Res. 2013;11(4):e65022. doi:

Abstract

Background: Hypertension is the most prevalent risk factor for arterial disease in the industrialized world and is a frequently encountered clinical problem in the aircrew population. Arterial systolic and diastolic blood pressures are continuously varying quantities, influenced by a host of extraneous factors. Aviators with hypertension responsive to life-style modifications should have serial BP rechecks quarterly to semi-annually during the first year to assure success of the lifestyle modifications. Failure to achieve blood pressure control with lifestyle modifications, or an initial blood pressure average exceeding 160 mmHg systolic or 100 mmHg diastolic, requires initiation of pharmacotherapy. Material and Methods: In this study we evaluate books, magazines, articles ، guidelines and reliable websites related to aeromedical concerns and waiver considerations in aircrew with hypertension. Results: Two major “types” of essential hypertension are generally recognized. One is characterized by suppressed renin activity and sensitivity to dietary sodium, the other by high renin activity and a lack of response to sodium intake. Thiazide diuretics are certainly the initial therapy of choice, particularly for older subjects. Aircrew with blood pressure that is controlled adequately with thiazides, with no other uncontrolled cardiovascular risk factors, and with no evidence of end-organ damage, are usually fit to return to unrestricted flying in military and civilian spheres. ACE inhibitors are an alternative initial choice in younger aviators, are positively indicated in patients with type 2 diabetes, and have no adverse effects on serum lipids. Conclusions: Hydrochlorothiazide (hctz), with or without triamterene or potassium replacementt, can be used as a first line agent for treatment of hypertension in designated personnel. ACE inhibitors might have an adverse effect on G-tolerance have not been borne out by experience in either the US Air Force or the Royal Air Force (RAF), and the US Navy accepts these agents for unrestricted flying without G-tolerance testing.

Highlights

Fulltext

Full text is available in pdf

References

  • 1.
    References are available in pdf.

Copyright

© 2013, Annals of Military and Health Sciences Research. This open-access article is available under the Creative Commons Attribution-NonCommercial 4.0 (CC BY-NC 4.0) International License (https://creativecommons.org/licenses/by-nc/4.0/), which allows for the copying and redistribution of the material only for noncommercial purposes, provided that the original work is properly cited.

Similar Articles

7
Nov
2012
Hyperventilation in Military Aviation and Diving

Hyperventilation in Military Aviation and Diving

Hamzeh Shahali,
Azadeh Amirabadi farahani

Shahali H, Amirabadi farahani A. Hyperventilation in Military Aviation and Diving. Ann Mil Health Sci Res. 2012;10(4):e68144. doi:

31
Mar
2000
Evaluation of awareness, treatment and drug consumption in hypertensives

Evaluation of awareness, treatment and drug consumption in hypertensives

HR Javadi

Javadi H. Evaluation of awareness, treatment and drug consumption in hypertensives. J Inflamm Dis. 2024;3(4):e154681. doi:

11
Nov
2015
A Survey of initial symptom of hypertension in hypertensive patients referred to special clinics of Kermanshah University of Medical Sciences in 2014

A Survey of initial symptom of hypertension in hypertensive patients referred to special clinics of Kermanshah University of Medical Sciences in 2014

Mahmud Fakhri,
Tahereh Salemi,
Sooma Mahmudian‏,
Samira Fatahi,
Farshid Amiri,
Shirin Gholanbar‏ ‏Zardui ‎

Fakhri M, Salemi T, Mahmudian‏ S, Fatahi S, Amiri F, et al. A Survey of initial symptom of hypertension in hypertensive patients referred to special clinics of Kermanshah University of Medical Sciences in 2014. J Clin Res Paramed Sci. 2015;4(3):e82042. doi:

24
Dec
2019
Antihypertensive Medications Awareness Level of Patients with Hypertensive Crisis

Antihypertensive Medications Awareness Level of Patients with Hypertensive Crisis

Mona Dastgheib,
Mani Dastgheib,
Minoo Shaddel,
Iraj Mirzaii-Dizgah

Dastgheib M, Dastgheib M, Shaddel M, Mirzaii-Dizgah I. Antihypertensive Medications Awareness Level of Patients with Hypertensive Crisis. Zahedan J Res Med Sci. 2012;14(10):e93211. doi:

1
Mar
2018
Prevalence of Pre-hypertension and Risk Factors in an Iranian Population: East of Iran

Prevalence of Pre-hypertension and Risk Factors in an Iranian Population: East of Iran

Toba Kazemi,
Tahmine Tavakoli,
Morteza Hajihosseini,
Elahe Yari

Kazemi T, Tavakoli T, Hajihosseini M, Yari E. Prevalence of Pre-hypertension and Risk Factors in an Iranian Population: East of Iran. Int Cardiovasc Res J. 2018;12(1):e10335. doi:

More by these authors

Mahmud momenzadehPubMedScholar
Ahmad ebadiPubMedScholar
Reza eslamiPubMedScholar
Amir khoshvaghtiPubMedScholar
Share
Cited by
Metrics